[Hyderabad, May 15th, 2025] – The global genomics market is undergoing an unprecedented transformation, projected to grow from USD 23.8 billion in 2024 to USD 54.2 billion by 2031, according to ClearView Market Insights’ 340-page genome-scale analysis.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-genomics-market/

1. The Clinical Genomics Revolution

• Cancer Diagnostics:
   - 38% of oncology spend now on genomic testing
   - Guardant's liquid biopsy detects 92% of Stage I cancers
• Rare Disease Solutions:
   - 5-year diagnostic odysseys reduced to 11 weeks
   - 78% cost reduction since 2019

2. The CRISPR Therapy Tipping Point

• Sickle Cell Cure:
   - Vertex's exa-cel shows 89% efficacy
   - USD 2M price tag sparks reimbursement wars
• Agricultural Breakthroughs:
   - Corteva's drought-resistant wheat increases yields by 38%

3. The Data Deluge Challenge

• Storage Needs:
   - 40 exabytes of genomic data by 2031
   - Google's DeepVariant reduces compute costs by 72%

 

About ClearView Market Insights

 

ClearView Market Insights is a globally recognized research firm specializing in industrial automation, logistics, and smart manufacturing. Our reports provide data-driven insights to help businesses navigate evolving markets.

 

 For more insights, visit https://clearviewmarketinsights.com/

 Media contact:

Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369